Literature DB >> 3109662

What happens to opiate addicts immediately after treatment: a prospective follow up study.

M Gossop, L Green, G Phillips, B Bradley.   

Abstract

In the first British study to investigate systematically what happens to opiate addicts after treatment 50 opiate addicts admitted for inpatient treatment of their drug dependence were followed up for six months after discharge. All had been withdrawn from opiates before follow up. Six months later 26 were not using opiates: 12 had not used opiates at any time since discharge. When subjects in hospital or in prison were excluded from the analysis 21 (47%) of the subjects living in the community were not taking opiates. Many subjects used opiates within days of leaving the inpatient unit, but this first lapse did not necessarily lead to a full relapse into addictive use. During the six months after discharge several subjects used opiates on a less than daily basis. During each two month period throughout the six months of follow up the proportion of subjects who were occasional users fell, the proportion of abstinent subjects grew, and the proportion of daily users (assumed to be readdicted) remained constant. Although many of the addicts relapsed soon after treatment, it was encouraging that almost half were opiate free after six months. These results have important implications for the treatment of drug addicts.

Entities:  

Mesh:

Year:  1987        PMID: 3109662      PMCID: PMC1246547          DOI: 10.1136/bmj.294.6584.1377

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  8 in total

1.  Opiate withdrawal: inpatient versus outpatient programmes and preferred versus random assignment to treatment.

Authors:  M Gossop; A Johns; L Green
Journal:  Br Med J (Clin Res Ed)       Date:  1986-07-12

2.  Relapse rates in addiction programs.

Authors:  W A Hunt; L W Barnett; L G Branch
Journal:  J Clin Psychol       Date:  1971-10

3.  A test of Wikler's theory of relapse: the frequency of relapse due to conditioned withdrawal sickness.

Authors:  W E McAuliffe
Journal:  Int J Addict       Date:  1982-01

4.  Dependence, relapse and extinction: a theoretical critique and a behavioral examination.

Authors:  G K Litman; J R Eiser; C Taylor
Journal:  J Clin Psychol       Date:  1979-01

5.  Differences in relapse precipitants and coping behaviour between alcohol relapsers and survivors.

Authors:  G K Litman; J R Eiser; N S Rawson; A N Oppenheim
Journal:  Behav Res Ther       Date:  1979

6.  Relapse in opiate addicts: a behavioral analysis.

Authors:  E F Chaney; D K Roszell; C Cummings
Journal:  Addict Behav       Date:  1982       Impact factor: 3.913

7.  Prescribing methadone for the opiate addict: a problem of dosage conversion.

Authors:  A R Johns; M Gossop
Journal:  Drug Alcohol Depend       Date:  1985-09       Impact factor: 4.492

8.  Seven-year follow-up of heroin addicts: drug use and outcome.

Authors:  G V Stimson; E Oppenheimer; A Thorley
Journal:  Br Med J       Date:  1978-05-06
  8 in total
  10 in total

1.  [The drug addict in prison: Medical response and its limitations].

Authors:  R Jeanmonod; T Harding
Journal:  Soz Praventivmed       Date:  1988

2.  Responding flexibly but not gullibly to drug addiction.

Authors:  J Strang; H Ghodse; A Johns
Journal:  Br Med J (Clin Res Ed)       Date:  1987-11-28

3.  Implicit and explicit drug-related cognitions during detoxification treatment are associated with drug relapse: an ecological momentary assessment study.

Authors:  Reshmi Marhe; Andrew J Waters; Ben J M van de Wetering; Ingmar H A Franken
Journal:  J Consult Clin Psychol       Date:  2012-12-10

4.  Extended release drug delivery strategies in psychiatry: theory to practice.

Authors:  Steven J Siegel
Journal:  Psychiatry (Edgmont)       Date:  2005-06

5.  Early outcomes following low dose naltrexone enhancement of opioid detoxification.

Authors:  Paolo Mannelli; Ashwin A Patkar; Kathleen Peindl; Edward Gottheil; Li-Tzy Wu; David A Gorelick
Journal:  Am J Addict       Date:  2009 Mar-Apr

6.  Employment-based abstinence reinforcement following inpatient detoxification in HIV-positive opioid and/or cocaine-dependent patients.

Authors:  Kelly E Dunn; Michael Fingerhood; Conrad J Wong; Dace S Svikis; Paul Nuzzo; Kenneth Silverman
Journal:  Exp Clin Psychopharmacol       Date:  2014-02       Impact factor: 3.157

7.  Very low dose naltrexone addition in opioid detoxification: a randomized, controlled trial.

Authors:  Paolo Mannelli; Ashwin A Patkar; Kathi Peindl; David A Gorelick; Li-Tzy Wu; Edward Gottheil
Journal:  Addict Biol       Date:  2008-08-19       Impact factor: 4.280

Review 8.  The clinical relevance of neurocognitive measures in addiction.

Authors:  Reshmi Marhe; Maartje Luijten; Ingmar H A Franken
Journal:  Front Psychiatry       Date:  2014-01-10       Impact factor: 4.157

Review 9.  Opioid Addiction: Social Problems Associated and Implications of Both Current and Possible Future Treatments, including Polymeric Therapeutics for Giving Up the Habit of Opioid Consumption.

Authors:  M Cristina Benéitez; M Esther Gil-Alegre
Journal:  Biomed Res Int       Date:  2017-05-18       Impact factor: 3.411

10.  Open label trial of naltrexone implants: measuring blood serum levels of naltrexone.

Authors:  Ross M Colquhoun
Journal:  Subst Abuse       Date:  2013-05-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.